share_log

The Latest Analyst Ratings For Immunocore Hldgs

The Latest Analyst Ratings For Immunocore Hldgs

Immunocore Hldgs的最新分析师评级
Benzinga ·  08/28 08:00  · 评级/大行评级
In the last three months, 7 analysts have published ratings on Immunocore Hldgs (NASDAQ:IMCR), offering a diverse range of perspectives from bullish to bearish.
在最近的三个月里,有7名分析师对Immunocore Hldgs(纳斯达克代码:IMCR)发表了评级意见,涵盖了从看好到看淡的不同观点。
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
总结他们最近的评估,下表展示了过去30天内不断变化的情绪,并将其与之前的几个月进行了比较。
Analysts have recently evaluated Immunocore Hldgs and provided 12-month price targets. The average target is $83.29, accompanied by a high estimate of $100.00 and a low estimate of $66.00. Observing a downward trend, the current average is 4.58% lower than the prior average price target of $87.29.
净利率:Immunocore Hldgs的净利率令人印象深刻,超过行业平均水平。净利率达到-15.41%,公司展示了强大的盈利能力和有效的成本管理。
Breaking Down Analyst Ratings: A Detailed Examination
分析师评级分析:详细分析
An in-depth analysis of...
债务管理:...
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发